Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Bioventus (BVS) Depreciation & Amortization (IS) (2020 - 2025)

Bioventus' Depreciation & Amortization (IS) history spans 6 years, with the latest figure at $1.3 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (IS) fell 26.64% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $5.7 million, down 25.16%, while the annual FY2025 figure was $5.7 million, 25.16% down from the prior year.
  • Depreciation & Amortization (IS) reached $1.3 million in Q4 2025 per BVS's latest filing, down from $1.4 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $3.3 million in Q2 2022 to a low of $1.3 million in Q4 2025.
  • Average Depreciation & Amortization (IS) over 5 years is $2.0 million, with a median of $2.0 million recorded in 2021.
  • The largest YoY upside for Depreciation & Amortization (IS) was 69.04% in 2022 against a maximum downside of 43.02% in 2022.
  • A 5-year view of Depreciation & Amortization (IS) shows it stood at $2.7 million in 2021, then crashed by 43.02% to $1.5 million in 2022, then skyrocketed by 36.23% to $2.1 million in 2023, then fell by 15.89% to $1.8 million in 2024, then dropped by 26.64% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for BVS's Depreciation & Amortization (IS) are $1.3 million (Q4 2025), $1.4 million (Q3 2025), and $1.4 million (Q2 2025).